Compare WST & TROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | WST | TROW |
|---|---|---|
| Founded | 1923 | 1937 |
| Country | United States | United States |
| Employees | N/A | 4802 |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.9B | 26.1B |
| IPO Year | 2004 | 2000 |
| Metric | WST | TROW |
|---|---|---|
| Price | $361.16 | $104.18 |
| Analyst Decision | Buy | Sell |
| Analyst Count | 7 | 11 |
| Target Price | ★ $325.86 | $98.00 |
| AVG Volume (30 Days) | 350.9K | ★ 1.2M |
| Earning Date | 04-23-2026 | 04-30-2026 |
| Dividend Yield | 0.30% | ★ 5.18% |
| EPS Growth | ★ 1.49 | 0.98 |
| EPS | 4.07 | ★ 5.10 |
| Revenue | ★ $2,886,900,000.00 | $2,370,700,000.00 |
| Revenue This Year | $6.76 | $5.48 |
| Revenue Next Year | $6.22 | $1.56 |
| P/E Ratio | $90.06 | ★ $20.16 |
| Revenue Growth | 1.95 | ★ 26.65 |
| 52 Week Low | $223.83 | $85.22 |
| 52 Week High | $386.00 | $122.00 |
| Indicator | WST | TROW |
|---|---|---|
| Relative Strength Index (RSI) | 62.59 | 30.80 |
| Support Level | $346.45 | $101.55 |
| Resistance Level | $367.66 | $107.09 |
| Average True Range (ATR) | 7.91 | 1.98 |
| MACD | 2.74 | -0.59 |
| Stochastic Oscillator | 80.35 | 22.24 |
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
T. Rowe Price provides asset management services for individual and institutional investors. It offers a broad range of no-load US and international stock, hybrid, bond, and money market funds. At the end of May 2026, the firm had $1.892 trillion in managed assets, composed of equity (49%), balanced (37%), fixed-income and money market (11%), and alternative (3%) offerings. Approximately two-thirds of managed assets are held in retirement-based accounts, which provide T. Rowe Price with a somewhat stickier client base than most of its peers. The firm also manages private accounts, provides retirement planning advice, and offers discount brokerage and trust services. The company is primarily a US-based asset manager, deriving less than 10% of its AUM from overseas.